Skip to main content

Longboard Pharmaceuticals, Inc.

LBPHDelisted Dec 2, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001832168

Longboard Pharmaceuticals, Inc. was delisted on Dec 2, 2024; its insiders filed their last Form 4 on Dec 2, 2024; 125 institutions reported holding it in 13F filings for Q3 2024, worth $1.33B in total; Viking Global Investors was the only superinvestor holding it.

Q3 2021 vs. Q2 2021

How the institutions holding Longboard Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of LBPH: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders1720+3
Shares7.98M7.67M−305.6K (−3.8%)
Value$71.7M$68.2M−$3.51M (−4.9%)

New holders (6)

Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to LBPH in Q3 2021
InstitutionSharesValue% of portfolio
Bridgeway Capital Management, LLC70,000$624.0K0.01%
Veritable, L.P.20,534$182.0K0.00%
Bank of America Corp16,072$142.0K0.00%
Geode Capital Management, LLC15,177$135.0K0.00%
ExodusPoint Capital Management, LP12,073$107.0K0.00%
Migdal Insurance & Financial Holdings Ltd.1,753$16.0K0.00%

Sold out (3)

Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of LBPH in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Millennium Management LLC54,443$497.0K
Renaissance Technologies LLC10,400$95.0K
Advisory Services Network, LLC1,000$9.00K